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Abstract 
Does a country’s economic structure matter for health outcomes? This study, for the first 
time, examines the extent to which the mix of products a country produces and exports 
affects population health. For this purpose, I employ the Economic Complexity index 
(ECI) that relies on the sophistication of export bundles to extract information on the 
availability of productive capabilities within an economy. Using unbalanced panel data 
for up to 112 countries covering the period from 1970 to 2015, I find that countries 
exporting complex products have better health status than countries whose economic 
structure is mainly based on unsophisticated goods. To account for endogeneity concerns, 
I exploit regional averages of ECI in neighbouring countries to isolate the plausibly 
exogenous component of complexity that helps achieve a causal interpretation. The 
results lend credence to the main proposition that increased ECI is associated with health 
improvements. The main findings offers several implications for designing health and 
industrial development policies. 
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1. Introduction 
A key line of inquiry in development economics attempts to investigate the relationship 
between economic development and health outcomes (see, for instance, Pritchett & Summers, 
1996). It is well established in this strand of literature that income levels are positively 
associated with health improvements. On that basis, Dollar (2001) documents that an increase 
in trade openness and globalization is conducive to national health status, which is in part 
attributable to their growth-enhancing effects. Subsequent studies attend to this body of 
research, and find that trade openness may improve population health through affecting 
economic growth, poverty and inequality (Deaton, 2003;  Levine & Rothman, 2006), 
knowledge spillovers (Owen & Wu, 2007), and public health expenditure (Kumar et al., 2013). 
Other scholars put a premium on the role of globalization in driving changes in nutrition that 
help better health status (e.g., Oberlander et al., 2017;  Cuevas  et al., 2019).1 
A brief review of the literature exploring the development-health nexus reveals that a 
higher level of trade openness helps foster economic prosperity not only through enhancing 
robust growth but also through health improvements (Dollar, 2001). Nevertheless, previous 
studies have predominantly relied on using simple aggregate measures of trade flows (e.g., the 
sum of exports and imports as a proportion of total GDP) to quantitatively assess the impact of 
trade liberalization on health status (e.g., Owen & Wu, 2007). A key drawback of this approach 
is that it fails to reflect the quality or sophistication of products a country produces and exports. 
Recent studies emphasize that different types of products are associated with differentiated 
economic outcomes (Hausmann et al., 2007;  Hidalgo & Hausmann, 2009;  Hartmann et al., 
2017;  Lee & Vu, 2019). This leaves it open to debate whether the sophistication of a country’s 
export bundle matters for health outcomes, which is the main question to be answered in this 
study. For this reason, a key distinguishing feature of this paper is to demonstrate that exporting 
a diverse range of complex products is linked to better health outcomes. 
 More specifically, the main inquiry of this paper is motivated by some recent 
contributions to the empirical growth literature that emphasize the role of a country’s economic 
structure in affecting economic performance. Hausmann et al. (2007), for instance, propose 
that the mix of products embedded in countries’ economic structure lies at the root of global 
income differences. Accordingly, countries producing sophisticated high-end manufactures, 
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 While most studies find that trade liberalization is good for population health, there exist several papers arguing 
that increased trade lowers health outcomes through enhancing disease spread (see, e.g., Case & Deaton, 2006;  
Ruhm, 2007;  Oster, 2012). See also Blouin et al. (2009) for a review of related research. 
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such as automobiles and electronics, enjoy more robust economic growth, thus being relatively 
wealthier (Hausmann et al., 2007). Employing international trade data, Hidalgo and Hausmann 
(2009) recently develop the Economic Complexity index (ECI) that provides an internationally 
comparable measure of productive capabilities.2 The underlying logic of this indicator holds 
that economic development is the process through which a country acquire new capabilities, 
including physical capital (e.g., transportation and communication systems), human capital 
(e.g., knowledge and skills), and institutions (e.g., legal systems) (Hidalgo & Hausmann, 2009). 
However, capturing such diverse and complex productive capabilities across countries appears 
to be difficult. Therefore, Hidalgo and Hausmann (2009) rely on countries’ export bundles to 
quantify the set of productive capabilities that plays a key role in driving future patterns of 
economic growth across countries. 
In other words, the availability of productive capabilities, regarded as non-tradeable 
inputs of production, can be captured by the capacity to produce and export a diverse range of 
sophisticated products (Hidalgo & Hausmann, 2009). It follows from this method that not only 
the volume of exports but also the sophistication level of export bundles matters for future 
growth and development (Hausmann & Hidalgo, 2011;  Felipe et al., 2012;  Hausmann et al., 
2014). Furthermore, Hartmann et al. (2017) and Lee and Vu (2019) find that exporting complex 
products is associated with a more egalitarian distribution of income within an economy. 
Importantly, existing studies mainly focus on exploring the effect of ECI on economic growth 
and income inequality levels. By contrast, little attention is paid to understanding the extent to 
which economic complexity, which captures productive capabilities within a country, matters 
for population health. This inquiry is important because it may advance our understanding of 
the link between economic development and health outcomes.3 It is also interesting to 
investigate whether growth based on complex products (high complexity) is associated with 
better health outcomes than growth induced by unsophisticated goods (low complexity). As 
such, the types of growth and exports are relevant for health improvements, besides growth 
rates and trade volumes as established in earlier studies. A better understanding of these 
relationships is particularly important for designing health policies, as discussed later. 
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 More details about this index are contained in Section 2 and the online Appendix. 
3
 It is important to emphasize that health outcomes are key indicators of well-being, besides GDP per capita. Thus, 
a large number of studies attempt to explain cross-country differences in health status. It is also widely perceived 
that economic development is a multi-dimensional process. Thus, income per capita is an imperfect measure when 
it comes to explaining comparative development across the globe. Surprisingly, the literature linking economic 
structures and economic performance have largely overlooked the multi-faceted nature of economic development. 
Hence, it is crucial to investigate the link between economic structures and health outcomes.  
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The main hypothesis of this study postulates that exporting sophisticated products, 
captured by higher levels of economic complexity, is associated with better health outcomes. 
There are several arguments supporting the positive link between ECI and health status. 
First, an increase in economic complexity reflects enhanced capacity to produce a 
diversified set of sophisticated products. The complexity of a country’s economic structure is 
a key factor affecting social choices and human capabilities, which include, but are not limited 
to, occupational and learning opportunities (Hartmann, 2014;  Hartmann et al., 2017). 
Therefore, an individual living in a simple economy driven by the production of limited low 
value-added commodities is constrained by few employment opportunities. By contrast, people 
living in a complex economy that produces a variety of sophisticated products are subject to 
more occupational choices. Importantly, it is well established that an individual’s occupational 
status is a crucial determinant of people’s health conditions (see, for instance, Morris et al., 
1994;  Martikainen & Valkonen, 1996;  Strully, 2009).4 Furthermore, economic growth driven 
by exporting complex goods with increasing returns provides sustained income and profits over 
prolonged periods (Reinert, 2008). High and sustained levels of income lead to health 
improvements by enhancing expenditure on goods and services (e.g., nutrition, clean water, 
improved sanitation facilities and medical services) (Pritchett & Summers, 1996;  Dollar, 2001;  
Deaton, 2003;  Levine & Rothman, 2006). For these reasons, producing sophisticated products 
helps improve national health status.  
Second, some recent contributions to understanding the relationship between economic 
structure and comparative prosperity emphasize that various types of products are linked to 
differences in institutional quality, and the distribution of power and income within an 
economy. Indeed, the method of constructing ECI, as presented in Section 2, builds upon the 
intuition that sophisticated products, such as machinery, chemical and metals, are typically 
made in complex economies with inclusive institutions and high levels of human capital 
(Fukuyama, 1996;  Hidalgo & Hausmann, 2009;  Hidalgo, 2015). Khan (2010, 2013) argues 
that countries specializing in a limited number of simple products, like agricultural 
commodities, raw materials and resources, suffer from poor institutional quality because the 
returns from enforcing the rule of law and property rights are insufficient to cover the cost of 
enforcement. Indeed, previous studies have early revealed that post-colonial countries 
specializing in low value-added agricultural or mineral products are likely to experience an 
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 More specifically, employment status may affect health outcomes through several factors, such as social status 
and self-esteem, the consumption of alcohol and tobacco, and material deprivation (see, e.g., Herzer, 2017).  
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unbalanced power distribution, thus suffering from poor institutional quality, inadequate 
human capital and lower income levels (Innis, 1970;  Engerman & Sokoloff, 1997;  Acemoglu 
& Robinson, 2012).5 Recently, Hartmann et al. (2017) point out that economic complexity co-
evolves with institutional changes because the survival of firms depends on the ability to 
establish institutions that perform best in the industry they are operating. In this regard, 
institutions are generally created at the work place, which varies significantly across industries. 
Sophisticated products, therefore, are positively linked to the inclusiveness of institutions.  
In less complex economies, a lack of diverse economic activities is associated with a 
more unequal power distribution and a vertical hierarchy in the occupational structure, which 
tend to emerge to manage a huge cadre of unskilled workers (Hartmann, 2014;  Hartmann et 
al., 2017;  Lee & Vu, 2019). Their economic structures are typically dominated by one main 
sector (agriculture or mineral industries) with limited social and employment choices. Hence, 
an economic premium tends to accrue to a few individuals with superior skills and knowledge, 
with the cost borne by the rest of the population. It follows from this argument that non-diverse 
economies mainly based on natural resources are characterized by an unequal distribution of 
power and income (Engerman & Sokoloff, 1997;  Collier, 2008;  Hartmann, 2014). 
Furthermore, exporting a range of sophisticated products with increasing returns helps sustain 
a strong tax base. Conventional wisdom in the public health literature postulates that fiscal and 
organizational capacity, which partly form good institutions, determines the extent to which a 
country can deliver an efficient tax-funded health system that helps improve population health 
(Besley & Kudamatsu, 2006;  Fafchamps, 2006;  Knowles & Owen, 2010).6 Furthermore, it is 
widely acknowledged that income inequality is harmful to health outcomes (see, for instance, 
Pickett & Wilkinson, 2015). Therefore, economic complexity betters health outcomes through 
fostering inclusive institutions, and lowering inequality in income and power.7 
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 The relationship between economic complexity and institutions is consistent with an influential view in the 
comparative development literature positing the colonial origins of income differences (Acemoglu et al., 2001). 
In particular, extractive industries and institutions were set up in places where the disease environment made it 
difficult for European colonizers to settle down permanently. By contrast, inclusive institutions and non-extractive 
were established in areas with favour disease conditions.  
6
 In particular, the quality of institutions, reflected in security of property rights, the effectiveness of governance, 
and the capacity to control corruption, are of importance for establishing an efficient public health system and 
infrastructure (Fafchamps, 2006). Furthermore, strong fiscal capacity provides resources for state provision of 
health services (e.g., clean water, sanitation facilities, treatment of infectious diseases), which helps achieve better 
health outcomes (Besley & Kudamatsu, 2006).   
7
 See Hartmann et al. (2017) and Lee and Vu (2019) for discussions on the link between ECI and income 
inequality. 
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Finally, economic complexity reflects the availability of knowledge and knowhow within 
a country (Hidalgo & Hausmann, 2009;  Hidalgo, 2015;  Hartmann et al., 2017). For this reason, 
the capacity to produce sophisticated products critically depends on the quality of human 
capital and knowledge, which may be hard to find in resource-rich or less complex economies. 
On the one hand, knowledge and education are widely acknowledge as promoting population 
health. On the other hand, Wigley (2017) argues that countries whose production is mainly 
based on resources or unskilled labour invest less in health improvements mainly because non-
tax revenues are readily available in these societies. By contrast, the government in complex 
or resource-poor economies tends to rely more on tax revenues, stemming mainly from high-
productivity production. These sophisticated activities in turn require a healthy and well-
educated population. Therefore, countries exporting complex products are more motivated to 
invest in health improvements, leaving them with better health status. In line with this 
argument, several studies find that countries specializing in agricultural products or resources 
have lower incentives to invest in public goods such as health or education (e.g., Cockx & 
Francken, 2014, 2016;  Wigley, 2017). Therefore, economic complexity acts as a catalyst for 
investment in public health systems and infrastructure, which arguably helps achieve better 
health outcomes.  
The above narrative suggests that economic complexity is positively associated with 
health outcomes. This hypothesis is empirically tested using unbalanced panel data for up to 
112 countries from 1970 to 2015. To preview my main findings, the pooled OLS and two-way 
fixed effects estimates reveal that economic complexity helps lower infant, under-five and 
neonatal mortality rates, and improve life expectancy at birth. The results are largely robust to 
controlling for a number of key determinants of health outcomes, and unobserved country- and 
year-specific factors. A key threat to obtaining causal interpretations in the development-health 
literature is potential endogeneity concerns. To address these issues, this study constructs a 
time-varying instrumental variable for economic complexity based on regional averages of 
complexity levels. The IV-2SLS estimates lend support to the main hypothesis of this research, 
accounting for an extensive set of confounding factors and potential weak instrument bias. I 
also perform other sensitivity tests, including estimating different sub-samples and removing 
outliers. None of these empirical exercises alters the core results. To summarize, this paper 
documents a robust effect of economic complexity on health outcomes, which has been largely 
ignored in previous studies. Importantly, the main findings offer several implications for 
designing health policies as discussed in Section 5.  
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The rest of the study is structured as follows. Section 2 presents the baseline econometric 
model and descriptions of variables and data sources. Section 3 discusses main findings, 
followed by the results of robustness checks in Section 4. Section 5 concludes by summarizing 
the core results and presenting some policy implications.  
2. Empirical approach 
Econometric specification 
To estimate the effect of ECI on health outcomes, I specify the following econometric model: 𝐻𝑒𝑎𝑙𝑡ℎ𝑖𝑡 = 𝛼 + 𝛽𝐸𝐶𝐼𝑖𝑡 + 𝛾𝑋𝑖𝑡 + 𝜇𝑖 + 𝜏𝑡 + 𝜀𝑖𝑡 
where 𝐻𝑒𝑎𝑙𝑡ℎ𝑖𝑡 stands for different measures of health outcomes of country i in period t. 𝐸𝐶𝐼𝑖𝑡 
is an index of economic complexity, capturing the sophistication of a country’s economic 
structures. 𝛽 reflects the estimated effect of ECI on population health. 𝑋𝑖𝑡 denotes a set of main 
control variables as explained below. 𝜇𝑖 is unobserved heterogeneity across countries. 𝜏𝑡 is 
unobserved time-specific factors. 𝜀𝑖𝑡 is an overall error term. To reduce potential measurement 
bias and short-run fluctuations because of business cycles, I employ data for five-year non-
overlapping time intervals (𝑇 = 10), covering the period from 1970 to 2015.8 
Variables and data 
 The main variable of interest in this paper is ECI, obtained from the MIT’s Observatory of 
Economic Complexity (https://oec.world/en/). This indicator is constructed using international 
trade data from the United Nations Comtrade database to measure cross-country differences in 
the sophistication of economic structure, using the method of reflections (e.g., Hidalgo & 
Hausmann, 2009;  Hausmann & Hidalgo, 2011;  Hausmann et al., 2014). 
More specifically, Hidalgo and Hausmann (2009) attempt to capture the complexity of 
countries’ economic structure based on the diversity of an economy (the number of products it 
exports with RCA) and the ubiquity of its products (the number of countries that exports a 
given product with RCA).9 The underlying logic of this approach holds that complex 
economies are characterized by the ability to produce and export a diverse set of sophisticated 
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 Data for health outcomes, obtained from the World Bank’s World Development Indicators, are available on an 
annual basis based on linear interpolation. Furthermore, some control variables are provided for every five-year 
periods. Thus, I construct unbalanced data using five-year intervals. This approach has been widely applied in the 
empirical growth literature (see, e.g., Berg et al., 2018).  
9
 RCA stands for the Revealed Comparative Advantage (Balassa, 1965). The main motivation of considering RCA 
is to account for variations in the size of countries and of product markets to obtain an internationally comparable 
metric across countries (Hausmann & Hidalgo, 2011).  
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products with low ubiquity because only a limited number of countries with enhanced 
productive capabilities can produce these sophisticated goods. By contrast, simpler economies 
possess limited productive capabilities, thus exporting a less diversified set of ubiquitous 
products. Felipe et al. (2012) find that the most sophisticated products are machinery, 
chemicals and metals while the least sophisticated goods are raw materials, agricultural 
products, wood, and textiles. As argued by Hidalgo and Hausmann (2009), measuring 
productive capabilities, which may include infrastructure systems, the quality of human capital, 
institutional quality, and other non-tradeable inputs of production, is challenging. For this 
reason, we can rely on what a country exports to extract information on its productive capacity, 
which plays a key role in driving future prosperity (Hidalgo & Hausmann, 2009). 
The measures of Diversity and Ubiquity are computed as follows. 
𝐷𝑖𝑣𝑒𝑟𝑠𝑖𝑡𝑦 = 𝑘𝑐,0 = ∑ 𝑀𝑐𝑝𝑁𝑝𝑝=1  
𝑈𝑏𝑖𝑞𝑢𝑖𝑡𝑦 = 𝑘𝑝,0 = ∑𝑀𝑐𝑝𝑁𝑐𝑐=1  
where c and p stands for the country and product, respectively. 𝑀𝑐𝑝 equals one if country c 
exports product p with RCA, and zero otherwise.  
The method of reflections relies on computing jointly and iteratively the average value 
calculated in the preceding iteration. According to Hidalgo and Hausmann (2009), this iterative 
process starts with the measure of Diversity (𝑘𝑐,0) that captures the number of products a 
country exports in a given year. Next, Ubiquity (𝑘𝑝,0)  is utilized to incorporate information on 
the ubiquity level of these products. This helps provide information on the number of products 
a country exports weighted by the ubiquity of these products. The process also takes into 
consideration the average diversity of countries exporting the same products as country c. This 
iterative process ends when no further information can be obtained from the previous iteration. 
Following Hidalgo and Hausmann (2009), the nth iteration can be written as follows. 
𝑘𝑐,𝑛 = 1𝑘𝑐,0 ∑ 𝑀𝑐𝑝𝑁𝑝𝑝=1 𝑘𝑝,𝑛−1 
where 
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𝑘𝑝,𝑛−1 = 1𝑘𝑝,0 ∑𝑀𝑐𝑝𝑘𝑐,𝑛−2𝑁𝑐𝑐=1  
Substituting 𝑘𝑝,𝑛−1 into 𝑘𝑐,𝑛, we obtain 
𝑘𝑐,𝑛 = 1𝑘𝑐,0 ∑ 𝑀𝑐𝑝𝑁𝑝𝑝=1 1𝑘𝑝,0 ∑ 𝑀𝑐′𝑝𝑘𝑐′,𝑛−2𝑁𝑐′𝑐′=1  
As demonstrated by Hausmann et al. (2014), it can be re-expressed as follows. 𝑘𝑐,𝑛 = ∑𝑀𝑐𝑐′̃ 𝑘𝑐′,𝑛−2𝑐′  
in which ?̃?𝑐𝑐′ = ∑𝑀𝑐,𝑝𝑀𝑐′,𝑝𝑘𝑐,0𝑘𝑝,0𝑝  
Finally, the vector of all ECI values for each country is given by. 
𝐸𝐶𝐼𝑐 = ?⃗? − 〈?⃗? 〉𝑠𝑡𝑑(?⃗? )  
in which ?⃗?  is the eigenvector of ?̃?𝑐𝑐′ associated with the second largest eigenvalue, as denoted 
by Hausmann et al. (2014). 〈 . 〉 and 𝑠𝑡𝑑 stands for average and standard deviation, respectively. 
Following the existing literature, I employ different measures of population health as 
dependent variables, including infant, under-five, and neonatal mortality rates, and life 
expectancy at birth. All data are taken from the World Bank’s World Development Indicators. 
Using various measures of health outcomes helps reduce measurement bias. Furthermore, I 
incorporate a number of key determinants of national health status in the regression to reduce 
omitted variable bias.10 As discussed earlier, income plays an important role in health 
improvements (Pritchett & Summers, 1996;  Dollar, 2001). Part of my arguments presented 
above also suggest that ECI may foster robust economic growth through which it betters health 
status. To mitigate a concern that the health impact of ECI may just proxy for income levels, I 
include GDP per capita as a control variable. Furthermore, other studies suggest that 
institutional quality (Fafchamps, 2006;  Rajkumar & Swaroop, 2008;  Knowles & Owen, 2010;  
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 Later, I account for measurement and omitted variable bias more thoroughly by adopting plausibly exogenous 
sources of variation in economic complexity (Section 4).   
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Li et al., 2018), urban population (Li et al., 2018), trade openness (Owen & Wu, 2007), 
democracy (Besley & Kudamatsu, 2006), and income inequality (Pickett & Wilkinson, 2015) 
may exert an influence on health outcomes. These variables, therefore, are included in the set 
of baseline control variables. Further, a set of country and year dummies are included to control 
for unobserved heterogeneity across countries and over the years.11 
3. Results 
Figure 1 illustrates the correlation between economic complexity and different measures of 
health outcomes. Accordingly, ECI is negatively correlated with infant, under-five and 
neonatal mortality rates, while we can observe a positive relationship between ECI and life 
expectancy at birth. This is largely consistent with the main proposition of this study. However, 
these findings may not imply causal interpretations other than simple correlations. 
To achieve causal inference on the effect of ECI on national health status, I estimate the 
benchmark model using pooled OLS (POLS) and two-way fixed effects (2FE) estimators. The 
core results are reported in Table 1. In particular, I incorporate a set of baseline control variables 
in all regressions to reduce omitted variable bias. To control for unobserved country- and time-
specific factors, country and year dummies are added to columns (2), (4), (6) and (8). Table 1 
demonstrates that the estimated coefficients of ECI have expected signs, and are statistically 
significant at the 1% level except in column (5). More specifically, increased economic 
complexity exerts a negative influence on mortality rates (columns 1-6). I also find that ECI 
has a statistically significant and positive impact on life expectancy at birth, ceteris paribus. 
These results lend support to the hypothesis that the sophistication of a country’s economic 
structure helps improve health outcomes. The findings are broadly robust to accounting for key 
determinants of population health established in previous studies. The magnitude of the 
estimated coefficients of ECI varies significantly when I account for unobserved heterogeneity 
across countries and over years. Nevertheless, the baseline findings retain their signs and 
significance levels in all cases, controlling for these time-invariant factors. In addition, my 
findings are largely insensitive to using different measures of population health (Table 1).12 
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 More details on variables’ descriptions and data sources are presented in the online Appendix. 
12
 The estimated coefficients also suggest that economic complexity exerts a sizeable influence on health 
outcomes. For instance, the results reported in column (8) of Table 1 indicate that a one-unit increase in ECI is 
associated with approximately a 1.3-year increase in life expectancy, a sizeable effect. This lends support to the 
economic importance of economic complexity in affecting population health.  
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The inclusion of baseline control variables is mainly motivated by the existing literature 
exploring the macroeconomic determinants of health outcomes. It is important to note that 
controlling for these variables helps factor out the effect of ECI on health outcomes from these 
confounding factors. This issue can also be addressed by employing the exogenous component 
of economic complexity, as discussed later. The estimated coefficients of these controls are 
consistent with the findings of previous studies, except for income per capita and trade 
openness. In particular, I find that the estimated effect of income levels and trade liberalization 
is relatively sensitive to controlling for unobserved country- and year-specific characteristics 
and economic complexity.13 As presented in Table 1, the coefficients of these variables become 
imprecisely estimated in some cases, and their signs are in contrast to the findings in earlier 
studies (see, for instance, Pritchett & Summers, 1996;  Dollar, 2001;  Deaton, 2003;  Levine & 
Rothman, 2006;  Owen & Wu, 2007). 
For instance, trade openness is found to increase mortality rates and has no statistically 
significant influence on life expectancy in columns (2), (4), (6) and (8). Furthermore, GDP per 
capita is positively linked to infant and under-five mortality rates, and its effect on life 
expectancy is imprecisely estimated, as shown in columns (2), (4) and (8) of Table 1. This is 
because the existing literature largely fails to incorporate the sophistication of a country’s 
products when exploring the determinants of health outcomes. My findings, therefore, suggest 
that economic complexity plays a more important role on health status. These results reinforces 
the argument that health improvements depend not only on trade flows or the rate of economic 
growth but also on the sophistication of exports and the types of economic growth. In this 
regard, economic growth mainly based on exporting less complex products (e.g., agriculture or 
resources) may be harmful for population health. By contrast, growth driven by exporting a 
diverse range of sophisticated commodities (e.g., high-technology manufactures) with 
increasing returns helps improve health outcomes. Therefore, the types of growth are of 
importance when it comes to explaining health outcomes. 
Turning to other covariates, the signs of their estimated coefficients are broadly in line 
with expectations. In particular, the fraction of urban population is associated with better health 
outcomes in all cases, which is consistent with the findings of Li et al. (2018). Further, 
institutional quality is widely documented in the public health literature as a key determinant 
of health outcomes (Fafchamps, 2006;  Rajkumar & Swaroop, 2008;  Knowles & Owen, 2010;  
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 The inclusion of country and year FE helps account for the effect of several economic, cultural and political 
factors that are a key concern in cross-country studies. 
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Li et al., 2018). The theoretical reasoning discussed in Section 1 suggests that the quality of 
institutions may be one potential channel of transmission from ECI to health outcomes. 
However, the main findings remain precisely estimated even when I control for institutions. 
This suggests that my results do not merely capture the health effect of institutions established 
in the literature. The level of income inequality has a negative impact on health outcomes, but 
the estimated coefficients of this variable are statistically insignificant at conventionally 
accepted levels in some cases (Table 1). In line with Besley and Kudamatsu (2006), I find that 
democracy betters population health. 
In summary, I find that increased economic complexity exerts a positive influence on 
population health, regardless of using any measures of national health status. The findings also 
remain precisely estimated after I control for an extensive set of key determinants of population 
health, and unobserved heterogeneity across countries and over years.14 
4. Robustness checks 
Endogeneity concerns 
A major threat to identification stems from endogeneity concerns, partly induced by reverse 
causation running from population health to economic performance (Levine & Rothman, 2006;  
Owen & Wu, 2007).15 Furthermore, omitted variable and measurement error bias may 
confound the main results. Addressing these issues requires isolating the exogenous component 
of economic complexity from which we can draw causal inference. 
The present study offers a novel empirical approach to the development-health literature 
by exploiting the spatial distribution of economic complexity across countries to perform IV-
2SLS regressions. The underlying logic of this method is that regional averages of ECI 
(ECI_ravg) are strongly correlated with a country’s complexity levels. This assumption is 
supported by a recent paper demonstrating that a country tends to export products currently 
exported by a neighbouring country (Bahar et al., 2014). The explanation for this finding holds 
that geographic proximity fosters the diffusion of knowledge and technologies, thus driving 
economic complexity of neighbouring countries. In addition, economic complexity levels may 
                                                          
14
 The baseline estimates are largely robust to accounting for other determinants of health, such as public health 
expenditures, access to sanitation, and years of schooling. However, incorporating these variables in the regression 
constrains the feasible sample size significantly, making it difficult to obtain an overall understanding of the 
complexity-health relationship. This is mainly because of the scarcity of data over the period 1970-2015. For this 
reason, I do not include them as main controls. These results are available upon request. 
15
 Health capital is a key determinant of productivity. Thus, counties with healthier workers may enjoy higher 
levels of economic complexity. 
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transcend national borders through peer pressure and imitation effects (Buera et al., 2011;  
Giuliano et al., 2013). These results suggest that ECI_ravg is not a weak instrument.16 Recently, 
Acemoglu et al. (2019), and Gründler and Krieger (2016) adopt a similar approach by using 
regional waves of democratization as a valid instrument for a country’s own democracy to 
estimate its causal effects on economic growth. In addition, Cherif et al. (2018) use averages 
of export sophistication in neighbouring countries as an instrument for a country’s national 
export sophistication in growth regressions. Therefore, I exploit the regional averages of ECI 
to isolate plausibility exogenous variations in each country’s complexity levels in a given year. 
A key assumption is that ECI_ravg exerts no direct influence on a country’s health 
outcomes, conditional on controlling for a set of covariates. It is important to emphasize that 
we cannot empirically test the exogeneity condition mainly because of the unobserved nature 
of the error term. Nevertheless, we can identify potential channels that may invalidate the 
instrument, and incorporate them in the regression. Acemoglu et al. (2019), in particular, 
control for several confounding factors to mitigate potential deviation from the exclusion 
restrictions. As such, the exogeneity assumption is satisfied conditional on accounting for a 
range of confounding factors. Countries located in the same region may share common fixed 
factors, like geography, climate, and cultures that arguably affect the regional dissemination of 
economic complexity and health outcomes. I account for this possibility by including country 
FE in all regressions to control for these unobserved time-invariant traits. Furthermore, health 
outcomes can be affected by spillover effects from proximate economies mostly through trade 
and capital flows, which facilitate technological transfers. I account for this mechanism by 
maintaining the use of trade openness as a control variable.17 Additional controls to reduce 
potential deviation from the exclusion restrictions will be used later. 
To construct ECI_ravg, I divide the sample into seven disjoint regions, following the 
World Bank’s classifications.18 The calculation can be expressed as follows. 
𝐸𝐶𝐼_𝑟𝑎𝑣𝑔𝑖𝑡 = 1𝑁𝑟𝑡 − 1 ∑ 𝐸𝐶𝐼𝑗𝑡𝑁𝑟𝑡−𝑖𝑗≠𝑖  
                                                          
16
 Later, I also perform several tests of robust inference to weak instruments.  
17
 Capital flows may be captured by FDI, which is highly correlated with trade openness. Therefore, I do not 
include it the same regression with trade openness. Using FDI as a control variable, however, does not alter my 
results (available on request). Baseline control variables are included in all IV regressions. 
18
 Acemoglu et al. (2019) employ the same classifications of regions. Each country is assigned to exactly one 
particular region as classified by the World Bank.  
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where 𝑁𝑟𝑡 denotes the number of countries in region 𝑟 at year 𝑡. 𝑗 stands for neighbouring 
countries of domestic country 𝑖. For each country in a given year, I calculate the averages of 
economic complexity of neighbouring countries located in a particular region, excluding a 
country’s own ECI values. A broad definition of regions tends to remove the regional variation 
in ECI that may directly affect domestic health outcomes, but this may reduce the correlation 
between ECI_ravg and ECI. By contrast, a narrower definition may increase the possibility 
that I include neighbouring countries that directly affect domestic health, but this can reduce 
weak instrument bias. Hence, a crucial issue is the choice of region classifications. For this 
reason, I also use a narrower definition of regions, following Gründler and Krieger (2016). 
More details on these are provided in the online Appendix. 
According to the results shown in panel B of Table 2, ECI in neighbouring countries has 
a positive and statistically significant effect on a country’s economic complexity. The results 
reveal that being proximate to countries exporting sophisticated products helps improve the 
sophistication of a country’s own economic structure. This lends support to the findings of 
Bahar et al. (2014). A number of weak instrument tests are also reported in Panel C of Table 
2. These results provide strong evidence that ECI_ravg is not a weak instrument.19 As a final 
robustness check for the instrument’s relevance, I report additional results in Panel D of Table 
2, following Andrews et al. (2019). Specifically, Andrews et al. (2019) recommend reporting 
the effective first-stage F-statistic proposed by Olea and Pflueger (2013) for non-
homoscedastic, serially correlated, and clustered data when testing for weak instruments. In all 
cases, the effective F-statistic is much larger than the rule-of-thumb of 10, which lends 
credence to the instrument’s relevance. Furthermore, Andrews et al. (2019) suggest relying on 
identification-robust Anderson-Rubin confidence intervals. In the case of a single instrument, 
these confidence sets are efficient regardless of the strength of the instrument in the reduced-
form regression. The results reveal that the zero value lies outside the 95% confidence intervals 
in all cases, supporting the interpretation of statistically significant findings.20 
As represented in panel A of Table 2, the exogenous component of ECI is found to lower 
mortality rates and improve life expectancy. The effect is also precisely estimated at the 1% 
                                                          
19
 In particular, the F-statistic value of excluded instrument is much larger than the rule-of-thumb value of 10. I 
also obtain broadly similar results when performing the Anderson-Rubin test of robust inference to weak 
instrumentation. Furthermore, we can also reject the null that ECI_ravg is just weakly correlated with ECI when 
using the Cragg-Donald and Kleibergen-Paap Wald test.  
20
 This method adopts test reversion instead of using point estimates and standard errors because the IV estimates 
are non-normally distributed under the case of weak instruments. For more details see Andrews et al. (2019).  
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level of significance in all cases, which is consistent with the baseline estimates. However, the 
magnitude of the estimated coefficients is much larger than POLS and 2FE estimates reported 
in Table 1. Hence, the estimated effect of ECI on health outcomes is larger when using IV 
regression. This may correspond to downward bias induced by failure to account for potential 
unobserved time-varying factors or measurement errors. The results in Table 2 are largely 
robust to using different classifications of regions as discussed earlier. 
National health status may be affected by economic complexity levels of neighbouring 
countries through other potential channels, which include, but are not limited to, spillover 
effects and regional fixed traits. The inclusion of country FE and a measure of trade openness 
in the regression partly reduces this concern, as discussed earlier. In Table 3, I further address 
this problem by controlling for net migration and an index of globalization.21 A measure of 
population size is also incorporated in the model because larger countries may be less affected 
by their neighbours. Following Acemoglu et al. (2019), I include regional patterns of economic 
growth to further capture the spillover effects that may confound the validity of the 
instrument.22 This is because regional patterns of economic growth may trigger the 
dissemination of economic complexity and health technologies, thus invaliding the 
instruments. The inclusion of these additional controls nonetheless fails to alter the main 
findings. Overall, I attempt to control for a number of confounding factors in the IV regressions 
to mitigate any potential violations of the exclusion restrictions. The inclusion of these control 
variables also helps distinguish the regional dissemination of economic complexity from the 
effect of common region-specific factors, regional economic shocks, or the diffusion of 
economic conditions between countries in the same region through trade openness or other 
channels. Importantly, if the regional averages of ECI affect a country’s national health status 
through these channels, the exclusion restrictions are still satisfied conditional on incorporating 
them in the regression. For this reason, I may isolate a plausibly exogenous source of variation 
in complexity that helps achieve causal inference. 
In summary, this section exploits the plausibly exogenous component of ECI, based on 
knowledge diffusion, peer pressure and imitation effects, to estimate achieve causal inference. 
                                                          
21
 The KOF globalization index reflects the global integration of not only economic but also political and cultural 
activities. 
22
 Acemoglu et al. (2019) postulate that regional waves of democratization may directly affect a country’s 
economic growth through spillover effects. The authors account for this channel of influence by incorporating 
regional growth in the regression. In the same vein, regional patterns of economic growth may be correlated with 
the regional diffusion of economic complexity and health outcomes.   
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Compared with the baseline results, the IV estimates give larger estimated coefficients when I 
attempt to account for endogeneity concerns. However, my findings remain precisely estimated 
at the 1% level of significance across different model specifications. The results, therefore, 
provide evidence of a positive effect of economic complexity on population health.  
Other robustness checks 
I provide the results of additional sensitivity tests in the online Appendix. First, I test for 
robustness to sample selection by excluding Asia, Oceania, Africa, Europe, and America from 
the regression. Following Knowles and Owen (2010), I also remove countries with a 
communist legacy.23 African countries are characterized by significantly poorer health, which 
may drive the core results. The exclusion of other continents also mitigates a concern that the 
core results just proxy for regional differences in economic performance and health outcomes. 
Nevertheless, the core findings retain their signs and significance levels (the Appendix Tables 
A1 and A2). Second, I check for robustness to removing outliers based on estimating the 
Cook’s distance, standardized errors and robust regression weights. The results and detailed 
explanations are presented in the Appendix Table A3. Accordingly, the effect of economic 
complexity on national health status remains precisely estimated at the 1% level of significance 
when I estimate restricted samples excluding potential outliers.  
5. Conclusion 
The link between economic performance and population health is a key topic of fruitful 
discussions among economists and policymakers. It is widely acknowledged in this line of 
inquiry that increased income and trade openness lead to health improvements. Nevertheless, 
previous studies exploring this issue largely fail to incorporate the sophistication of a country’s 
products, which has been linked to differentiated economic outcomes. In this regard, this paper 
goes beyond the current literature by postulating that countries exporting complex products 
enjoy lower mortality rates and longer life expectancy at birth than their counterparts exporting 
unsophisticated goods. Employing the Economic Complexity index, this study employs 
unbalanced panel data for up to 112 countries from 1970 to 2015, and finds strong evidence 
supporting the positive relationship between complexity and health status. My findings are 
largely insensitive to accounting for an extensive set of control variables and unobserved 
heterogeneity. I also address potential endogeneity concerns by exploiting regional averages of 
                                                          
23
 These countries experienced a negative health shock when they transformed themselves from socialist systems, 
with free healthcare, to market economies, with inadequately managed and often corrupt public health systems. 
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economic complexity to as an instrumental variable, which provides a valid basis for causal 
inference. Accordingly, the IV estimates are largely consistent with the main findings. 
Furthermore, the IV results are also robust to testing for weak instrument bias and controlling 
for a number of confounding factors. 
This study reveals that the complexity of countries’ economic structure, which represents 
the mix of products they produce and export, is highly predictive of not only economic growth 
but also health outcomes. Furthermore, different types of products are associated with different 
health outcomes, which advances our understanding of the development-health nexus. More 
specifically, increased trade flows or income based on exporting a diverse range of 
sophisticated products is more conducive to population health. For this reason, the types of 
growth and the quality of exports are of importance for health outcomes. Conventional wisdom 
in earlier research postulates that health improvements depend on the extent to which a country 
can provide an efficient tax-funded public health system and infrastructure, which is in turn 
linked to income levels and the quality of institutions (see, e.g., Pritchett & Summers, 1996;  
Deaton, 2003;  Fafchamps, 2006;  Rajkumar & Swaroop, 2008;  Knowles & Owen, 2010). In 
this regard, my findings demonstrate that the effectiveness of health policies, based on previous 
studies, can be limited in less complex economies essentially because the range of products 
embedded in their economic structure is a key factor affecting health outcomes. I believe that 
these results are particularly relevant for developing economies that typically suffer from poor 
health and low levels of economic complexity.  
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Figure 1. Economic complexity and health outcomes, averaged between 1970 and 2015 
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Table 1. Main results 
Dependent variables 
Infant mortality rate 
(Mort_inf)  
Under-five mortality rate 
(Mort_five)  
Neonatal mortality rate 
(Mort_neo)  
Life expectancy at birth 
(Lifexp) 
(1) (2)  (3) (4)  (5) (6)  (7) (8) 
            
ECI -4.440*** -10.777***  -10.507*** -19.363***  -1.050 -4.613***  2.028*** 1.282*** 
 [1.335] [2.407]  [2.263] [3.964]  [0.713] [1.201]  [0.378] [0.465] 
Log of GDP per capita -4.098*** 4.702*  -3.415 11.179**  -4.799*** -2.550**  0.858** 0.185 
 [1.430] [2.852]  [2.207] [4.623]  [0.753] [1.236]  [0.355] [0.562] 
Urban population -0.293*** -0.512***  -0.548*** -0.747***  -0.093*** -0.117*  0.104*** 0.066*** 
 [0.057] [0.165]  [0.091] [0.261]  [0.026] [0.063]  [0.017] [0.024] 
Institutional quality -6.014*** -4.075***  -8.775*** -6.441***  -2.421*** -1.654***  1.736*** 0.608*** 
 [0.791] [0.769]  [1.272] [1.209]  [0.381] [0.320]  [0.198] [0.145] 
Trade openness  -6.906*** 10.330***  -8.634*** 16.264***  -4.029*** 3.289***  0.336 -0.325 
 [1.698] [2.998]  [2.613] [4.793]  [0.931] [1.175]  [0.391] [0.427] 
Polity2  -0.751*** -0.583***  -1.085*** -0.969***  -0.293*** -0.215***  0.091** 0.041 
 [0.180] [0.141]  [0.275] [0.224]  [0.090] [0.061]  [0.040] [0.026] 
Income inequality 0.251** 0.385*  0.293* 0.390  -0.041 0.193*  -0.136*** -0.078* 
 [0.105] [0.222]  [0.157] [0.345]  [0.060] [0.106]  [0.031] [0.040] 
            
Year FE No Yes  No Yes  No Yes  No Yes 
Country FE No Yes  No Yes  No Yes  No Yes 
Observations 656 656  656 656  648 648  657 657 
R-squared 0.693 0.928  0.665 0.917  0.695 0.946  0.708 0.966 
Notes: This table represents the baseline estimates for the effect of economic complexity on health outcomes. A set of country and year dummies are included 
in columns (2), (4), (6), and (8) to perform two-way fixed effects regressions. The remaining columns report pooled OLS estimates. Variables’ descriptions and 
data sources are also provided in the online Appendix. Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. 
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Table 2. IV-2SLS estimates 
 
Regional averages of ECI 
(the World Bank’s classification)  
Regional averages of ECI 
(a narrower definition) 
Dependent variables  
Mort_inf  Mort_five  Mort_neo  Lifexp  Mort_inf  Mort_five  Mort_neo  Lifexp 
(1)  (2)  (3)  (4)  (5)  (6)  (7)  (8) 
Panel A. Second-stage estimates 
ECI -36.386***  -61.983***  -13.868***  5.583***  -29.036***  -48.725***  -9.655***  6.895*** 
 [7.130]  [11.419]  [3.387]  [1.324]  [7.519]  [11.927]  [3.341]  [1.784] 
Log of GDP per capita 11.993***  23.315***  0.508  -1.067  9.901**  19.540***  -0.884  -1.449* 
 [3.860]  [6.191]  [1.671]  [0.717]  [3.954]  [6.236]  [1.653]  [0.806] 
Urban population -0.051  0.021  0.042  -0.011  -0.183  -0.218  -0.030  -0.034 
 [0.187]  [0.302]  [0.081]  [0.032]  [0.170]  [0.271]  [0.073]  [0.039] 
Institutional quality -3.752***  -5.903***  -1.435***  0.551***  -3.844***  -6.071***  -1.534***  0.534*** 
 [0.857]  [1.343]  [0.337]  [0.152]  [0.797]  [1.243]  [0.306]  [0.163] 
Trade openness  17.986***  29.007***  6.120***  -1.611***  15.789***  25.043***  4.831***  -2.003*** 
 [3.919]  [6.433]  [1.637]  [0.620]  [3.681]  [5.952]  [1.456]  [0.739] 
Polity2  -0.386**  -0.640**  -0.132*  0.008  -0.442***  -0.742***  -0.170***  -0.002 
 [0.172]  [0.271]  [0.069]  [0.030]  [0.161]  [0.251]  [0.066]  [0.035] 
Income inequality  0.408*  0.428  0.208*  -0.081**  0.401*  0.417  0.201**  -0.083** 
 [0.238]  [0.379]  [0.109]  [0.039]  [0.223]  [0.350]  [0.101]  [0.042] 
                
Panel B. First-stage estimates. Dependent variable is ECI 
ECI_ravg 0.532***  0.532***  0.516***  0.532***  0.323***  0.323***  0.302***  0.324*** 
 [0.079]  [0.079]  [0.079]  [0.079]  [0.063]  [0.063]  [0.064]  [0.063] 
                
Panel C. Additional information 
Baseline controls Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Year FE Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Country FE Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
F-statistic of excluded  instruments  44.21  44.21  44.82  42.60  26.44  26.44  22.18  26.47 
Cragg-Donald Weak Identification 63.35  63.35  58.76  60.68  34.83  34.83  29.48  34.93 
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test 
Kleibergen-Paap Wald test 44.21  44.21  41.82  42.60  26.44  26.44  22.18  26.47 
Anderson-Rubin Wald test [p-
value] 
37.22 
[0.000] 
 37.22 
[0.000] 
 17.62 
[0.000] 
 20.22 
[0.000] 
 10.12 
[0.002] 
 10.12 
[0.002] 
 5.44 
[0.020] 
 17.88 
[0.000] 
Observations 656  656  648  657  656  656  648  657 
First-stage R-squared 0.957  0.957  0.958  0.957  0.955  0.955  0.956  0.955 
                
Panel D. Further evidence on instrument relevance 
Effective first-stage F-statistics 44.208  44.208  41.821  42.604  26.442  26.442  22.178  26.468 
Anderson-Rubin confidence 
intervals 
[-52.619,-
24.388] 
 [-87.981,-
42.767] 
 [-21.579, -
8.169] 
 [3.355, 
8.597] 
 [-44.665,-
14.896] 
 [-73.519,-
26.292] 
 [-16.601,-
3.371] 
 [3.892, 
11.311] 
Notes: This table reports IV-2SLS estimates for the effect of economic complexity on health outcomes. Country and time dummies are included in all 
regressions. Baseline control variables are also incorporated in the first-stage regressions but are omitted for brevity. These results are available on request. 
Panel C contains several diagnostic tests for weak instruments. The null hypothesis of the Anderson-Rubin Wald test is that the estimated effect of ECI on 
health outcomes in the structural equation equals zero. The null hypothesis of Kleibergen-Paap Wald test is that the instrument is weakly correlated with the 
endogenous regressor. Furthermore, the rejection of the null of this test should be based on Stock and Yogo’s critical values as follows: 16.38 (10% maximal 
IV size), 8.96 (15% maximal IV size), 6.66 (20% maximal IV size), 5.53 (25% maximal IV size). Panel D presents the results of additional tests for detecting 
weak instruments, as suggested by Andrews et al. (2019). In particular, the effective F-statistic provides valid inference on weak instrument even when data are 
non-homoscedastic, serially correlated, and clustered. In the case of a single endogenous regressor, the identification-robust Anderson-Rubin confidence sets 
provide efficient estimates regardless of the strength of the instrument in the reduced-form equation (Andrews et al., 2019). The classifications of regions are 
contained in the online Appendix. Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1.  
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Table 3. IV-2SLS estimates, additional controls 
 
Regional averages of ECI 
(the World Bank’s classification)  
Regional averages of ECI 
(a narrower definition) 
Dependent variables Mort_inf  Mort_five  Mort_neo  Lifexp  Mort_inf  Mort_five  Mort_neo  Lifexp 
 (1)  (2)  (3)  (4)  (5)  (6)  (7)  (8) 
Panel A. Second-stage estimates 
ECI -35.040***  -64.580***  -6.190*  3.729**  -27.621***  -47.166***  -5.623  7.640*** 
 [9.722]  [16.818]  [3.311]  [1.796]  [7.639]  [12.309]  [3.748]  [2.170] 
Net migration 0.007  0.010  0.005  -0.005**  0.012  0.021*  0.006  -0.003 
 [0.008]  [0.014]  [0.004]  [0.002]  [0.007]  [0.012]  [0.004]  [0.002] 
Globalization 0.607***  1.184***  -0.000  -0.129***  0.443**  0.863***  -0.013  -0.200*** 
 [0.193]  [0.338]  [0.061]  [0.038]  [0.177]  [0.295]  [0.074]  [0.053] 
Population  -0.010***  -0.017***  -0.006***  0.000  -0.009***  -0.015***  -0.006***  0.000 
 [0.001]  [0.002]  [0.000]  [0.000]  [0.001]  [0.002]  [0.001]  [0.000] 
Regional growth 6.551  13.988  -0.657  0.500  7.653**  11.159**  -0.057  0.789 
 [6.116]  [10.138]  [2.461]  [0.956]  [3.092]  [5.047]  [1.423]  [0.816] 
                
Panel B. First-stage estimates. Dependent variable is ECI 
ECI_ravg 0.515***  0.515***  0.487***  0.515***  0.264***  0.264***  0.239***  0.264*** 
 [0.109]  [0.109]  [0.109]  [0.109]  [0.062]  [0.062]  [0.062]  [0.062] 
                
Panel C. Other information 
Baseline controls Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Year FE Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Country FE Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
F-statistic of excluded instrument 22.36  22.36  20.11  22.36  18.15  18.15  14.75  18.15 
Observations 655  655  648  655  655  655  648  655 
First-stage R-squared 0.959  0.959  0.960  0.959  0.958  0.958  0.958  0.958 
Notes: Additional control variables, baseline controls, country and time dummies are included in all regressions. Other IV diagnostics as reported in Table 2 
remain largely unchanged. However, they are omitted for brevity. Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. See also notes to 
Tables 1 and 2. 
